Pradaxa and Electrolyte imbalance - a phase IV clinical study of FDA data

Summary:

Electrolyte imbalance is reported as a side effect among people who take Pradaxa (dabigatran etexilate mesylate), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Lasix, and have Stroke.

The phase IV clinical study analyzes which people have Electrolyte imbalance when taking Pradaxa. It is created by eHealthMe based on reports of 86,033 people who have side effects when taking Pradaxa from the FDA, and is updated regularly.

What is Pradaxa?

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.

What is Electrolyte imbalance?

Electrolyte imbalance is found to be associated with 1,088 drugs and 1,219 conditions by eHealthMe. Check the latest studies of Electrolyte imbalance.

On Aug, 04, 2026

86,033 people reported to have side effects when taking Pradaxa.
Among them, 39 people (0.05%) have Electrolyte imbalance.

Could Pradaxa cause Electrolyte imbalance?

Among these 39 people:

How long have people been on Pradaxa when they have Electrolyte imbalance? *

What is the gender of people who have Electrolyte imbalance when taking Pradaxa? *

female: 32.43 %
male: 67.57 %

What is the age of people who have Electrolyte imbalance when taking Pradaxa? *

What are other drugs people take besides Pradaxa? *

What are other side effects people have besides Electrolyte imbalance? *

Hypotension (abnormally low blood pressure): 10 people, 25.64%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 9 people, 23.08%
Cardiac Failure: 9 people, 23.08%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 9 people, 23.08%
Acute Kidney Failure: 7 people, 17.95%
Dehydration (dryness resulting from the removal of water): 7 people, 17.95%
Fall: 6 people, 15.38%
Nausea And Vomiting: 5 people, 12.82%
Diarrhea: 5 people, 12.82%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 5 people, 12.82%

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 15.38%
High Blood Pressure: 5 people, 12.82%
Osteoporosis (bones weak and more likely to break): 4 people, 10.26%
Pain: 3 people, 7.69%
Prostate Cancer Metastatic: 3 people, 7.69%
Prostate Cancer: 3 people, 7.69%
Neoplasm Malignant (cancer tumour): 2 people, 5.13%
Indigestion: 2 people, 5.13%
Oedema (fluid collection in tissue): 2 people, 5.13%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 1 person, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Pradaxa and have Electrolyte imbalance?

- Check whether Electrolyte imbalance is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pradaxa:

Pradaxa (86,906 reports)

Browse all side effects of Pradaxa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrolyte imbalance:

Electrolyte imbalance (1,088 drugs)

Browse all the conditions that are associated with Electrolyte imbalance:

Electrolyte imbalance (1,219 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dabigatran etexilate mesylate (the active ingredients of Pradaxa) and Pradaxa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.